August 20, 2013 | TranCelerate Biopharma reports that it has signed agreements facilitating head to head drug trials. The agreements allow drug makers to buy a competitor’s product for use in comparative clinical trials. The agreements are the first in a move toward more open drug development, TranCelerate says. Boston Business Journal